Hypoxia Stimulates Cytokine Production by Villous Explants from the Human Placenta
Overview
Authors
Affiliations
It has been hypothesized that inadequate placentation in the hypertensive disorder of pregnancy known as preeclampsia creates foci of placental ischemia/hypoxia leading to the elaboration of factors that compromise systemic endothelial function to produce disease sequelae. As tumor necrosis factor-alpha (TNF alpha) and interleukin-1 (IL-1) are inflammatory cytokines capable of eliciting endothelial cell dysfunction, we investigated whether the production of these inflammatory cytokines by cultured villous explants from the human placenta was affected by incubation in reduced oxygen (2% O2). The term placenta produced TNF alpha, IL-6, and low levels of IL-1alpha and IL-1beta under standard tissue culture conditions. Hypoxia significantly increased TNF alpha, IL-1alpha, and IL-1beta production by 2-, 6-, and 23-fold, respectively, but did not affect IL-6 production. Further, cytokines were immunolocalized to the syncytiotrophoblast layer as well as to some villous core cells. Hypoxic regulation of placental TNF alpha and IL-1beta production also appeared to differ based on gestational age. Finally, treatment with either cobalt chloride or an iron chelator mimicked the hypoxic response, suggesting that stimulation of placental cytokine production may involve a heme-containing, O2-sensing protein. These results suggest that placental hypoxia can lead to the elaboration of inflammatory cytokines, which may contribute to the pathophysiology of preeclampsia.
Chaiworapongsa T, Romero R, Gomez-Lopez N, Suksai M, Gallo D, Jung E Am J Obstet Gynecol. 2023; 230(4):450.e1-450.e18.
PMID: 37806612 PMC: 10990810. DOI: 10.1016/j.ajog.2023.10.002.
Hantoushzadeh S, Ahangari R, Balaneji S, Ghamari A, Hashemnejad M, Piri S Maedica (Bucur). 2023; 18(1):50-54.
PMID: 37266467 PMC: 10231157. DOI: 10.26574/maedica.2023.18.1.50.
Bueno-Sanchez J, Gomez-Gutierrez A, Maldonado-Estrada J, Quintana-Castillo J Front Endocrinol (Lausanne). 2023; 14:1087845.
PMID: 37206444 PMC: 10190602. DOI: 10.3389/fendo.2023.1087845.
Evaluation of maternal serum sestrin-2 levels in intrauterine growth restriction.
Ozturk Agaoglu M, Agaoglu Z, Yucel K, Ozturk F, Caglar T Ir J Med Sci. 2023; 192(5):2259-2264.
PMID: 36877413 DOI: 10.1007/s11845-023-03329-2.
Morgan Z, Bailey M, Trifonova D, Naik N, Patterson W, Lurmann F Environ Health. 2023; 22(1):11.
PMID: 36694159 PMC: 9872424. DOI: 10.1186/s12940-022-00951-y.